Cromoglicic acid Not Yet Recruiting Phase 2 Trials for Stroke, Ischemic / Post-stroke Cognitive Impairment Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03202147Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)